ClinicalTrials.gg
Active, not recruitingNCT07896044RCTUpdated Oct 26, 2026

Stoppa Approach Vs Anterior & Posterior Fixation in Management of BC Fracture Acetabulum

A Phase 2 interventional study of Sequential anterior and posterior approaches for double column acetabular fractures and Isolated Modified Stoppa approach for management of double column acetabular fractures in Evaluation of Isolated Stoppa Approach in BC Fracture Acetabulum, sponsored by Ain Shams University. Active, not recruiting at 1 site in Egypt. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Ain Shams University · Phase 2, Interventional, and Treatment

Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Phase 2
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
16 Years to 65 Years
Sex
All
01

Study summary

Double-column acetabular fractures are complex injuries that require stable anatomical reduction and fixation to restore hip function. These fractures may be treated using an isolated anterior approach with posterior column screw fixation or through sequential anterior and posterior column fixation. The relative benefits and risks of these two strategies remain uncertain.

This prospective randomized controlled trial will compare isolated fixation through the modified Stoppa approach with posterior column screws versus sequential anterior and posterior column fixation in participants with double-column acetabular fractures. Thirty participants will be randomly allocated to the two treatment groups. The study will compare radiological and functional outcomes, implant failure, recurrent diastasis, operative characteristics, complications, wound infection, and the need for additional surgery.

Read the detailed description

Double-column acetabular fractures are complex injuries that require stable anatomical reduction and fixation of both acetabular columns. Surgical management may be performed through an anterior intrapelvic approach with posterior column screw fixation or through sequential anterior and posterior column fixation. The optimal strategy remains uncertain because additional surgical exposure may improve direct visualization and fixation of the posterior column but may also increase operative time, blood loss, and approach-related morbidity.

This prospective randomized controlled clinical trial will compare isolated fixation through the modified Stoppa approach with posterior column screw fixation versus sequential anterior and posterior column fixation in the management of double-column acetabular fractures. The study will be conducted at Ain Shams University Hospitals. A total of 30 participants will be enrolled and allocated in a 1:1 ratio using a computer-generated randomization table. Fifteen participants will undergo fixation through an isolated modified Stoppa approach with posterior column screws, and 15 participants will undergo sequential anterior and posterior column fixation.

Preoperative assessment will follow Advanced Trauma Life Support principles. Initial fracture stabilization will be performed using appropriate skeletal traction when indicated. Clinical assessment will include documentation of associated injuries, medical comorbidities, medication use, and preinjury ambulatory status. Radiographic assessment will include anteroposterior pelvic radiographs, Judet views, and computed tomography for detailed evaluation and classification of the acetabular fracture according to the Letournel and Judet classification.

Surgery will be performed under general anesthesia on a radiolucent operating table. In the isolated anterior fixation group, acetabular exposure will be obtained through the modified Stoppa approach. A lateral window of the ilioinguinal approach may be added when visualization of the iliac wing or high anterior column is required. The modified Stoppa approach will provide access to the superior pubic ramus, pelvic brim, quadrilateral surface, anterior column, and medial surface of the posterior column. The corona mortis will be identified and ligated when present.

Fracture reduction will be performed under direct visualization using appropriate pelvic reduction instruments. Temporary fixation may be achieved using Kirschner wires. Definitive anterior fixation will be performed using precontoured 3.5-mm reconstruction plates along the pelvic brim, with supplementary infrapectineal buttress plating when required for quadrilateral surface involvement. Posterior column fixation will be achieved using column screws inserted under fluoroscopic guidance.

In the sequential fixation group, anterior and posterior column reduction and fixation will be performed sequentially through the planned anterior and posterior surgical exposures. Reduction and fixation of each column will be completed using reconstruction plates and screws according to the fracture configuration. Fluoroscopic anteroposterior, iliac oblique, and obturator oblique views will be used to assess fracture reduction and implant position in both study groups.

Postoperative management will follow a standardized protocol. Neurovascular assessment and postoperative pelvic radiographs will be performed after surgery. Antibiotic prophylaxis, thromboprophylaxis, analgesia, and rehabilitation will be provided according to the institutional protocol. Toe-touch weight bearing will be recommended during the initial six postoperative weeks, followed by progressive weight bearing and physiotherapy according to fracture stability and radiological progression.

Follow-up assessments will be conducted at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after surgery. Clinical evaluation will include hip range of motion, limb-length discrepancy, ambulatory status, and recovery of function. Radiological evaluation will include standardized pelvic radiographs to assess reduction maintenance, fracture healing, recurrent displacement, and implant integrity. Functional and radiological findings, complications, operative characteristics, and the requirement for additional surgical intervention will be compared between the two treatment groups.

02

Conditions studied

  • Evaluation of Isolated Stoppa Approach in BC Fracture Acetabulum

Keywords

  • Modified Stoppa approach
  • double column fracture
  • quadrilateral plate fractures
  • posterior column screws
  • both column fracture
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,932 studies on the registry; 433 are open to participants now.

Of its 33 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Double-column acetabular fracture

Age from 16 to 65 years, inclusive

Recent acetabular fracture sustained within 14 days before enrollment

Exclusion criteria

Exclusion Criteria:

Isolated anterior column fracture

Isolated posterior column fracture

Isolated anterior wall fracture

Isolated posterior wall fracture

Combined posterior wall and posterior column fracture

Previous surgical procedure involving the affected hip before the current injury

Pathological acetabular fracture

Open acetabular fracture

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Fixation of double column Fracture acetabulum via sequential anterior & posterior approaches

    anatomical reduction and fixation of double column fractures, starting with anterior approach and quadrilateral plate fixation, followed by posterior fixation via Kocher-Langenbeck approach

    Procedure: Sequential anterior and posterior approaches for double column acetabular fractures

  • Experimental
    Fixation of double column Fracture acetabulum via isolated Modified Stoppa approach

    anatomical reduction and fixation of double column fractures via isolated modified stoppa approach, utilizing anatomical quadrilateral plate and posterior column screws through the plate

    Procedure: Isolated Modified Stoppa approach for management of double column acetabular fractures

Interventions

  • ProcedureSequential anterior and posterior approaches for double column acetabular fractures

    starting with modified stoppa approach and suprapectineal plating, followed by the Kocher-Langenbeck approach and posterior column plating for double-column acetabular fractures

  • ProcedureIsolated Modified Stoppa approach for management of double column acetabular fractures

    anatomical reduction and fixation of double column acetabular fractures via single anterior approach, utilizing anatomical quadrilateral plate and posterior column screws

06

What researchers measure

Primary outcomes

  1. Rate of excellent, very good, good, average, or poor functional outcomes using the modified Merle d'Aubigné scoring system

    Clinical assessment was done via the Modified Merle d'Aubigné scoring system that was calculated at each follow-up visit (out of 18) and presented the mean value; the score evaluates three factors: pain, mobility \& ability to walk. The score maximum is 18 (excellent) and minimum is 6 (poor)

    Time frame: 1 year postoperative

  2. Rate of Anatomical, Congruent, or Incongruent Radiological Outcomes According to the Matta and Tornetta Radiological Principles

    Radiological outcomes will be evaluated according to the Matta and Tornetta Radiological Principles using anteroposterior pelvic radiographs. Assessment will be based on restoration of the five anatomical lines: the iliopectineal line, ilioischial line, acetabular dome, anterior wall, and posterior wall. Each participant will be classified into one of three ordered categories: Anatomical, representing the best radiological outcome; congruent, representing an intermediate radiological outcome with preserved joint congruence; or incongruent, representing the worst radiological outcome with loss of joint congruence. The number and percentage of participants in each category will be reported for each treatment group. This is a categorical classification rather than a numerical scale; therefore, numerical minimum and maximum values do not apply.

    Time frame: 1 year postoperative

  3. Rate of implant failure

    The incidence of implant failure will be compared between the isolated modified Stoppa approach with posterior column screw fixation group and the sequential anterior and posterior column fixation group. Implant failure will be defined as plate or screw breakage, bending, loosening, pull-out, migration, or loss of implant position identified on follow-up radiographs. Revision surgery performed because of mechanical failure of the fixation construct will also be recorded as an implant failure event. The rate will be calculated as the number of patients who develop implant failure divided by the total number of evaluable patients in each group, multiplied by 100.

    Time frame: Up to 12 months after surgery.

  4. Rate of recurrent fracture diastasis or secondary loss of reduction

    Recurrent fracture diastasis will be defined as an increase of more than 2 mm in the postoperative displacement or separation of either the anterior or posterior acetabular column compared with the immediate postoperative radiographs. Assessment will be performed using standardized anteroposterior pelvic and Judet radiographs, with computed tomography obtained when plain radiographs are inconclusive. Revision surgery due to recurrent displacement or loss of reduction will also be recorded as an event. The rate will be calculated as the number of affected patients divided by the total number of evaluable patients in each group, multiplied by 100.

    Time frame: From immediately after surgery through 12 months after surgery.

Secondary outcomes

  1. Mean intraoperative blood loss

    The mean blood loss was calculated and compared between the two study groups, it was measured intraoperative and postoperative from suction drains

    Time frame: up to 4 days postoperative

  2. Mean operative time

    The mean operation time was calculated in minutes and compared between the two study groups

    Time frame: It was calculated intraoperatively

  3. Rate of unplanned reoperation

    The incidence of unplanned reoperation related to the index acetabular fracture or its surgical fixation will be compared between the two treatment groups. Reoperation will include revision fixation, implant removal due to complications, surgical treatment of infection, conversion to total hip arthroplasty, or any other unplanned surgical procedure related to failure of the initial treatment. Routinely planned procedures unrelated to a complication will not be considered reoperations. The reoperation rate will be calculated as the number of patients requiring at least one unplanned additional operation divided by the total number of evaluable patients in each group, multiplied by 100. The indication and type of each additional operation will also be recorded.

    Time frame: Up to 12 months after the index operation.

  4. Rate of postoperative surgical-site infection

    The incidence of postoperative surgical-site infection will be compared between the two treatment groups. Infection will be classified as superficial incisional infection, involving only the skin or subcutaneous tissue, or deep incisional infection, involving the deep soft tissues, fascia, muscle, or fixation implants. Diagnosis will be based on clinical findings such as purulent wound discharge, wound dehiscence, erythema, swelling, local tenderness, fever, positive microbiological culture, or the need for antibiotic or surgical treatment. The infection rate will be calculated as the number of patients diagnosed with a surgical-site infection divided by the total number of evaluable patients in each group, multiplied by 100.

    Time frame: p to 90 days after surgery. For implant-related or late infections, events will continue to be recorded for up to 12 months.

  5. Quality of intraoperative acetabular fracture reduction

    he quality of fracture reduction will be assessed intraoperatively after definitive fixation using fluoroscopic anteroposterior and Judet views. The maximum residual displacement or fracture gap involving the anterior column, posterior column, and articular surface will be measured in millimetres. Reduction will be classified according to the maximum residual displacement as anatomical (0-1 mm), imperfect (2-3 mm), or poor (greater than 3 mm). The measured displacement and distribution of reduction categories will be compared between the two treatment groups.

    Time frame: Intraoperatively, immediately after definitive fixation and before wound closure.

07

Study locations

1 site
  • Ain Shams University
    Cairo, Abassia 1234, Egypt
08

References and documents

Publications

  • Meena BP, Dhakar A, Meena UK, Behera P, Roat KL. Modified Stoppa Approach Alone or in Combination with a Lateral Window for Acetabular Fractures Involving Both Columns. Hip Pelvis. 2025 Sep 1;37(3):230-237. doi: 10.5371/hp.2025.37.3.230. PubMed 40889944 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 16, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Sep 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2026
First posted
Oct 26, 2026
StartActual
Sep 17, 2026
Primary completionEst.
Sep 16, 2027
CompletionEst.
Sep 17, 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07896044
Responsible party
Islam Moussa (Lecturer of orthopaedic surgery, Ain Shams University) — Principal investigator
First posted
Oct 26, 2026
Start date
Sep 17, 2026
Primary completion
Sep 16, 2027 (estimated)
Completion
Sep 17, 2027 (estimated)
Last update
Oct 26, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion